Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population.

ABSTRACT:

Importance

Direct costs of substance use disorders (SUDs) in the United States are incurred primarily among the working-age population. Quantifying the medical cost of SUDs in the employer-sponsored insurance (ESI) population can improve understanding of how SUDs are affecting workplaces and inform decision-making on the value of prevention strategies.

Objective

To estimate the annual attributable medical cost of SUDs in the ESI population from the health care payer perspective.

Design, setting, and participants

In this economic evaluation, Merative MarketScan 2018 databases were weighted to represent the non-Medicare eligible ESI population. Regression and mathematical modeling of medical expenditures controlled for insurance enrollee demographic, clinical, and insur

SUBMITTER: Li M 

PROVIDER: S-EPMC9972180 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature